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1123-40 Long-Term Outcome in Patients With Acute Myocardial 
Infarction Undergoing Primary Percutaneous 
Intervention: A Pooled Analysis of the Primary 
Angioplasty in Myocardial Infarction Trials 
C. Samuel Ledford. Cindy L. Grines, Gregg W. Stone, David Cox, Bruce Brodie, Lorelei 
Gdnes, Judith Boura, William W. O'Neill, Pdmary Angioplasty in Myocardial Infarction 
(PAMt) Group, William Beaumont Hospital, Royal Oak, Michigan. 
Background: Primary peroutaneous coronary intervention (PCI) at time of presentation 
for acute myocardial infarction has been shown to be an effective means of reperfusion. 
Short and long-term outcome data has been limited to reports in relatively smafl groups. 
This report reviews the in-hospital and long-term clinical outcome of patients randomized 
to PCI in the pooled databases of the PAMI trials. Factors predictive for adverse outcome 
in this group are analyzed. 
Methods: We performed a pooled analysis of a total of 2970 patients from the databases 
of 5 primary coronary intervention trials (PAMI-I, PAMI-2, Stent PAMI, Air PAMI and PAMI 
No Surgery on Site), treated with primary percutaneous intervention. We studied the inci- 
dence of procedural complications and in-hospital, thirty day, six-month and one-year 
outcomes (death, reinfarctlon and composite endpoint of death or reinfarction); and per- 
formed risk factor analysis for adverse outcomes. 
Results: Procedural success was achieved in 91% with TIMI-3 flow in 86%. 33% of 
patients underwent intracoronary stenting. In-hospital, 30-day, six-month and 1-year mor- 
tality were 3, 3,9, 5 and 6.4% respectively; with reinfarction occurring in 1, 1.4, 3.1 and 
4% of patients respectively. The combined endpoint of death or reinfarction occurred in 
3.2, 4.2, 7.9 and 9.8% respectively. Independent risk factors for adverse outcome at six 
months and one year were similar and included: age >70, heart rate >100, final TIMI flow 
<3, multivessel coronary disease, higher Killip class and lower ejection fraction. 
Conclusion: Primary PCI for acute MI is associated with favorable in-hospital and long- 
term outcome, with prognostic predictors similar to thrombolysis trials. However, given a 
three-fold increase in the risk of death or reinfarction after hospital discharge, more 
aggressive evaluation and treatment after discharge may be necessary. 
1123-41 Have the Outcomes of Rescue Angioplasty After Failed 
Thrombolytic Therapy in Acute Myocardial Infarction 
Improved in the Stent Era? 
Milena G. Adamian, Gregg W, Stone, Roxana Mehran, George Dangas, Andrea S. 
Abizaid, Alexander Abizaid, Mohamed Mohamed, Yuliya Adamyan, Arlene Reyes, Izat 
Hjazi, Ioannis lakovou, Makoto Hirose, Alexandra J. Lansky, Jeffrey W, Moses, Martin B. 
Leon, Lenox Hill Heart and Vascular Institute, New York, New York, Cardiovascular 
Research Foundation, New York, New York. 
Background: Compared to orimary balloon angioplasty (BA) in pts with AMI not receiv- 
ing antecedent thrombolytic therapy (TT), pts undergoing rescue BA after having 
received TT have reduced angiographic success rates and increased mortality and reinf- 
arction. Whether the outcomes of rescue intervention have improved with stant implanta- 
tion is unknown. 
Methods: We examined the early and late outcomes of 191 consecutive pts slanted 
within 12 hrs of AMI, 83 (43%) of who had received and clinically failed "iF (94% t-PAt 
mean time from symptom onset to TT 229 _+ 162 mini. Results: Compared to primary 
stent (PSi pts, those undergoing rescue stanting (RS) were younger (55 + 12 vs. 62 + 14 
yrs, p=0.0005), and were less likely to have suffered a prior CVA (2,4% vs. 14.0%, 
p=0.005) or undergone prior CABG (6.0 vs. 14.8%, p=O.05). Cardiogenic shock was 
present in 15.7% RS vs. 11.2% PS pts (p=NS), and tABP was required in 33.7% vs. 
24.1% respectively (p--0.14). GP lib/ilia inhibitors were used with similar frequency in 
both groups (30.1% vs. 26.9%, p=NS), Clinical outcomes appear in the Table. 
RS (n=63) PS (n=108) P-value 
TIMI-3 Flow Post Procedure (%) 93.3 98.7 0.99 
In-Hospital: 
Death (%) 2,4 5.6 0.47 
Reinfarctlon (%) 0 2.8 0.26 
CABG (%) 1.2 1.9 1.00 
TLR-PCI (%) 3.6 0.9 0.32 
MACE (%) 3.6 7.4 0.35 
Major Bleeding (%) 4.8 6.5 0.76 
1-Year: 
Death (%) 7.6 14.1 0.17 
Death - Non Shock pts (%) 6.1 6.9 0.42 
Q-wave MI (%) 5.4 4.6 0.99 
CABG (%) 2.7 1.2 0.59 
TLR-PCI (%) 4.1 7,1 0.51 
MACE (%) 18.8 23.0 0.49 
Conclusions: In contrast to the previously reported worse outcomes of rescue balloon 
angioplasty after thrombolytic therapy, in-hospital and long-term outcomes of rescue 
stenting after failed thrombolysis in AMI are favorable, and similar to that of primary 
stanting without lytic therapy. These data support re-examination of combination early 
pharmacologic reperfusion followed by interventional strategies in AMI. 
ABSTRACTS- Myocard ia l  In fa rc t ion  and  I schemia  309A 
1123-42 Stent ing  in Acute Myocardial Infarction in Patients With 
Chronic Renal Failure: Predictors of In-Hospital and 
Long-Term Outcome 
Milena G. Adamian, Roxana Mehran, George Dangas, Michael Farkhou, Alexandre 
Abizaid, Arlene Reyes, Izat Hjazi, Manuela Negoita, Mohamed Mohamed, Christian 
Cioara, Ramona Pop, Alexandra J. Lansky, Gregg W. Stone, Jeffrey W. Moses, Martin B. 
Leon, Lenox Hill Heart and Vascular Institute, New York, New York, Cardiovascular 
Research Foundation, New York, New York. 
Background: Although chronic renal failure (CRF) is associated with poor outcome after 
elective PCI, few data exist on clinical outcomes following slanting in acute myocardial 
infarction (AMI). 
Methods: AMI patients (n=382) presenting within 72 hours of symptom-onset were 
divided in 2 groups: 27 pts with CRI (baseline creatinine _> 1.5mg/dl), and without CRI 
(no-CRI, n=355). Pts on dialysis were excluded from the study. Clinical follow-up was 
obtained in 95% of the patients. 
Results: CRI pts were older (68 vs.61 years, p=0.005), had more often insulin-depen- 
dent diabetes (IDDM) (29.6% vs. 7.4%, p=0.001), history of stroke (25.9% vs.7.9%, 
p=0.O07), and congestive heart failure (18.5% vs. 6.2%, p=0.03) compared to no-CRI 
pts. Anglographic success was obtained in 100% lesions in CRI pts and 98.9% in non- 
CRI, p=NS. Mean contrast volume was similar between 2 groups (239-~131 vs.233.5+ 
106 ml, p=0.8). 
CRI (n=27) Non-CRI (n=355) p-value 
In-Hospitah 
Pulmonary Edema (%) 25.9 9.3 0.01 
Renal Failure (%) 23.1 4.3 0.002 
Stroke (%) 7.4 0.3 0.01 
Death (%) 11.1 3.4 0.08 
MACE (%) 11.1 4.5 0.1 
1-Year: Death (%) 17.4 7.9 0,1 
TVR (%) 10.0 11.1 0,1 
MACE (%) 26.1 15.8 0.2 
MACE=death, MI, any TVR; TVR= target vessel revasoularizatlon. 
By multivariate analysis female sex (OR=2.78; Ct [1.12; 6.67], p=0.03) and IDDM were 
identified as predictors of 1-year mortality (OR=3.11, CI [1.07-9.07], p=0.04). 
Conclusion: Primary stenting for AMI in CRF pts is associated with increased in-hospital 
complications and late mortality with similar reavscularization rates at 1 year. Increased 
late mortality in these pts is more likely secondary to higher comorbidities in this popula- 
tion. Female gender and DM remain as important independent predictors of late mortality 
after slanting. 
1123-43 Poor One Year Prognosis in Acute Myocardial Infarction 
Patients With Saphenous Vein Grafts as the Infarct 
Related Vessel Treated by Primary Balloon Angioplasty 
Thanh Ti Nouven, William W. O'Neill, Simon R. Dixon, Judith A. Boura, Lorelei Gdnes, 
David A. Cox, Gregg W. Stone, Bruce Brodie, Cindy L. Grines, William Beaumont 
Hospital, Royal Oak, Michigan. 
Background: Previous small observational studies suggest that acute infarct angloplasty in 
saphenous vein grafts (SVG) is associated with a high incidence of adverse clinical events 
compared with mechanical reperfuslon in native vessels. However, few data exist regarding 
long-term clinical outcome in this high-risk patient subgroup. Methods: In a pooled analysis 
of 3391 acute myocardial infarction (AMI) patients (< 12 hours from symptom-onset) from 
the PAMI-2, No Surgery-On-Site, Local PAMI, Stent-PAMI Randomized and Registry and 
Stent-PAMI Pilot were identified with a SVG as the culpdt vessel. Survival at 1-month, 6- 
months and 1-year was compared to patients undergoing mechanical reperfusion in a native 
vessel Results: Of the 3391 patients with AMI, 93 (3%) had a SVG as the infarct-related 
vessel (IRV). Compared with patients undergoing primary angioplasty in a native vessel, 
patients with a SVG culprit were older (67 vs, 81 yrs, p<0.00t ), more likely to have diabetes 
(32% vs. 18%, p=0.O01 ), a history of MI (48% vs. 14%, p=0.0Ot), have multi-vessel disease 
(94% vs. 48%, p--O,001 ), and a lower ejection fraction (43% vs. 49%, p=0.043). The inci- 
dence of initial TIMI-3 flow (10.8% vs. 11.1%, p=NS) and baseline diameter stenosis were 
similar between SVG and native vessel culprits. However, patients with a SVG culprit were 
less likely to achieve TIMI-3 flow after primary angloplasty (83% vs. 92%, p--O.O04) despite 
similar final diameter stenosis. Compared to native vessel PTCA, patients with a SVG culprit 
had a significant higher mortality at 1-month (8% vs. 4%, p=0,043), 6-months (10% vs. 5%, 
p=0.052) and 1-year (20% vs. 6%, p<0,001). Conclusion: Though TIMI-3 flow can be 
achieved in a relatively high percentage of patients with a SVG tRV, long-term mortality is 
higher than in patients with native vessel as the culprit. New mechanical approaches are 
needed to improve the post-procedural TIMI-3 flow and long term survival. 
1123-44 Ef fect  of  T reatment  With P late let  G lycoprote in  l ib/I l ia 
Inh ib i tors  on In-Hospital Outcomes of Patients Treated 
With Primary Angioplasty for Acute Myocardial 
Infarction 
Babak A. Vaki,, James N. S~atar, Warren Sherman, Kumar L. Ravi, Stephen J. Green, 
Timothy A. Sanborn, David L. Brown, Albert Einstein College of Medicine/Montefiore 
Medical Center, Bronx, New York. 
Background: Results of randomized clinical trials (RCT) differ regarding the effect of treat- 
ment with platalet glycoprotein lib/Ilia (GPI) inhibitors on outcomes following primary angio- 
pJasty (PPTCA) for acute myocardial infarction (AMI). Even less is known regarding the 
effects of GPI on outcomes of PPTCA outside of the setting of RCTs. We sought to deter- 
mine whether in-hospital OUtcomes following PPTCA are improved by GPI treatment. 
